Microbot Medical (NASDAQ:MBOT) Stock Price Passes Above 200 Day Moving Average of $5.38

Shares of Microbot Medical Inc. (NASDAQ:MBOTGet Rating) crossed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $5.38 and traded as high as $5.88. Microbot Medical shares last traded at $5.79, with a volume of 11,585 shares.

Microbot Medical Stock Down 1.9 %

The firm has a fifty day simple moving average of $5.17 and a 200-day simple moving average of $5.38. The company has a market cap of $41.16 million, a PE ratio of -3.15 and a beta of 3.55.

Institutional Investors Weigh In On Microbot Medical

Hedge funds have recently made changes to their positions in the business. Cetera Advisor Networks LLC acquired a new stake in shares of Microbot Medical during the first quarter worth about $78,000. Blueshift Asset Management LLC acquired a new stake in shares of Microbot Medical during the first quarter worth about $81,000. Finally, Renaissance Technologies LLC boosted its stake in shares of Microbot Medical by 52.5% during the first quarter. Renaissance Technologies LLC now owns 15,695 shares of the biotechnology company’s stock worth $98,000 after buying an additional 5,400 shares during the period. Institutional investors and hedge funds own 9.90% of the company’s stock.

Microbot Medical Company Profile

(Get Rating)

Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio.

Recommended Stories

Receive News & Ratings for Microbot Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbot Medical and related companies with MarketBeat.com's FREE daily email newsletter.